About
Adocia is a clinical-stage biotechnology company developing innovative formulations of insulins and other metabolic hormones to treat type 1 and type 2 diabetes as well as obesity.
Explore Adocia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.